Medline said the acquisition brings quality products, innovation, and expanded service offerings. Credit: Dmitry Kalinovsky / Shutterstock.

Medline Industries has closed the acquisition of Ecolab’s global surgical solutions business, for a total cash consideration of approximately $950m.

The acquisition, which includes the Microtek product lines, is aligned with Medline’s strategic growth objectives.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The move comes after the companies announced a definitive agreement in April 2024 for the acquisition.

As part of the agreement, Medline acquired Ecolab’s surgical solutions business operations, products, and team.

Medline said the acquisition improves its capabilities, bringing quality products, innovation, and expanded service offerings.

See Also:

Medline president and chief operating officer Jim Pigott said: “We are thrilled to officially welcome the nearly 3,500 Microtek surgical solutions business team members to the Medline family.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Our surgical solutions business is poised for a bright future as we continue to provide exceptional service and innovative solutions to our customers. With this acquisition, we are eager to collaborate with healthcare providers and cutting-edge medical device companies to bring innovative solutions to the surgical suite.”

The surgical products, advanced sterile drape solutions and OEM capabilities are expected to strengthen Medline’s portfolio.

Ecolab plans to use the proceeds from the sale, together with its balance sheet, to invest in ‘attractive growth opportunities’.

In a press statement, Ecolab said: “Ecolab will continue to serve hospitals through its infection prevention and instrument reprocessing businesses.

“Infection prevention provides environmental hygiene programmes to reduce hospital-acquired infections. Instrument reprocessing provides cleaning and sterilisation solutions for instruments, which fits well with Ecolab’s growth model as it combines a technological anchor with proprietary consumables and service.”